APYX
Apyx Medical Corp
Company overview
- Market capitalization
- $105.31M
- Employees
- 205
- Latest publication
- 2026-09-29
About Apyx Medical Corp
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q3 20162016-09-30 · USD | Q2 20162016-06-30 · USD | Q1 20142014-03-31 · USD | Q4 20132013-12-31 · USD | Q3 20132013-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,490,000USD | 19,164,000USD | 12,877,000USD | 10,063,000USD | 9,295,000USD | 6,482,000USD | 6,128,000USD | 5,794,000USD |
| Cost Of Revenue | 7,818,000USD | 21,176,000USD | 4,580,000USD | 5,001,000USD | 4,595,000USD | 3,726,000USD | 3,560,000USD | 3,545,000USD |
| Gross Profit | 4,672,000USD | -2,012,000USD | 8,297,000USD | 5,062,000USD | 4,700,000USD | 2,756,000USD | 2,568,000USD | 2,249,000USD |
| Research Development | 765,000USD | 944,000USD | 801,000USD | 682,000USD | 592,000USD | 332,000USD | 322,000USD | 291,000USD |
| Selling General Administrative | 8,071,000USD | 11,044,000USD | 1,481,000USD | 4,625,000USD | 4,618,000USD | 2,366,000USD | 2,523,000USD | 2,433,000USD |
| Unclassified Operating Expenses | -3,253,000USD | -14,011,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 5,583,000USD | -2,023,000USD | 9,129,000USD | 5,307,000USD | 5,210,000USD | 2,698,000USD | 2,845,000USD | 2,724,000USD |
| Operating Income | -911,000USD | 11,000USD | -832,000USD | -245,000USD | -510,000USD | 58,000USD | -876,000USD | -475,000USD |
| Interest Income | 244,000USD | 234,000USD | 292,000USD | — | — | — | — | — |
| Interest Expense | 1,369,000USD | 1,407,000USD | 1,413,000USD | 36,000USD | 50,000USD | 28,000USD | 66,000USD | 54,000USD |
| Net Interest Income | -1,125,000USD | -1,173,000USD | -1,121,000USD | — | — | — | — | — |
| Income Before Tax | -2,000,000USD | -1,146,000USD | -1,877,000USD | -964,000USD | -519,000USD | -9,569,000USD | -3,008,000USD | -516,000USD |
| Income Tax Expense | 143,000USD | 94,000USD | 78,000USD | 36,000USD | -123,000USD | 38,000USD | -539,000USD | -175,000USD |
| Tax Provision | 143,000USD | 94,000USD | 78,000USD | — | — | — | — | — |
| Net Income | -2,108,000USD | -1,299,000USD | -1,984,000USD | -964,000USD | -519,000USD | -9,607,000USD | -2,469,000USD | -341,000USD |
| Net Income From Continuing Ops | -2,143,000USD | -1,240,000USD | -1,955,000USD | -964,000USD | -519,000USD | -9,607,000USD | -5,696,000USD | -341,000USD |
| Ebit | -631,000USD | 261,000USD | -464,000USD | -928,000USD | -469,000USD | -174,000USD | -2,942,000USD | -462,000USD |
| Ebitda | -429,000USD | 482,000USD | -332,000USD | -727,000USD | -296,000USD | 58,000USD | -2,735,000USD | -258,000USD |
| Depreciation And Amortization | 202,000USD | 221,000USD | 132,000USD | 201,000USD | 173,000USD | 232,000USD | 207,000USD | 204,000USD |
| Reconciled Depreciation | 202,000USD | 221,000USD | 164,000USD | 201,000USD | 173,000USD | 232,000USD | 207,000USD | 204,000USD |
| Total Other Income Expense Net | -1,089,000USD | -1,157,000USD | -1,045,000USD | -719,000USD | -9,000USD | -9,627,000USD | -2,132,000USD | -41,000USD |
| Minority Interest | 35,000USD | -59,000USD | -29,000USD | — | — | 9,811,000USD | — | — |
| Selling And Marketing Expenses | — | — | 6,846,999USD | — | — | — | — | — |
| Non Operating Income Net Other | — | — | — | -719,000USD | -9,000USD | -9,627,000USD | -2,302,000USD | 13,000USD |
| Net Income Applicable To Common Shares | — | — | — | -964,000USD | -519,000USD | -9,607,000USD | -5,125,000USD | -341,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD | FY 20092009-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD | FY 20052005-12-31 · USD | FY 20042004-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 27,671,000USD | 25,411,000USD | 26,953,447USD | 28,096,510USD | 28,779,157USD | 26,676,182USD | 20,211,141USD | 20,495,101USD |
| Cost Of Revenue | 16,338,000USD | 14,680,000USD | 15,098,696USD | 16,247,702USD | 17,463,644USD | 16,075,426USD | 12,649,209USD | 12,514,063USD |
| Gross Profit | 11,333,000USD | 10,731,000USD | 11,854,751USD | 11,848,808USD | 11,315,513USD | 10,600,756USD | 7,561,932USD | 7,981,038USD |
| Research Development | 1,329,000USD | 1,197,000USD | 2,082,960USD | 2,060,854USD | 1,643,092USD | 1,187,088USD | 985,807USD | 907,389USD |
| Selling General Administrative | 8,958,000USD | 10,302,000USD | 9,056,942USD | 8,496,676USD | 7,565,915USD | 6,789,826USD | 5,755,807USD | 5,755,807USD |
| Total Operating Expenses | 10,287,000USD | 11,499,000USD | 11,139,902USD | 10,557,530USD | 9,209,007USD | 7,976,914USD | 7,157,964USD | 6,702,482USD |
| Operating Income | 1,046,000USD | -18,000USD | 714,849USD | 1,291,278USD | 2,106,506USD | 2,623,842USD | 403,968USD | 1,278,556USD |
| Interest Expense | 232,000USD | 249,000USD | 76,370USD | 58,463USD | 2,471USD | 16,157USD | 22,703USD | 15,090USD |
| Income Before Tax | 834,000USD | 32,000USD | 662,841USD | 2,777,211USD | 2,246,756USD | 2,710,773USD | 428,224USD | 1,266,729USD |
| Income Tax Expense | 217,000USD | -77,000USD | 67,319USD | 945,423USD | -148,835USD | 47,567USD | 32,016USD | -272,723USD |
| Net Income | 617,000USD | 109,000USD | 595,522USD | 1,831,788USD | 2,400,591USD | 2,683,206USD | 406,208USD | 1,511,993USD |
| Net Income From Continuing Ops | 617,000USD | 109,000USD | — | — | — | — | — | — |
| Ebit | 1,073,000USD | 269,000USD | 739,211USD | 2,835,670USD | 2,106,506USD | 2,623,842USD | 403,968USD | 1,278,556USD |
| Ebitda | 1,930,000USD | 1,194,000USD | 1,788,844USD | 3,808,739USD | 2,877,332USD | 3,153,102USD | 949,844USD | 1,673,675USD |
| Depreciation And Amortization | 857,000USD | 925,000USD | 1,049,633USD | 973,069USD | 770,826USD | 529,260USD | 545,876USD | 395,119USD |
| Total Other Income Expense Net | -212,000USD | 50,000USD | -52,008USD | 1,485,933USD | 140,250USD | 86,931USD | 24,256USD | -11,827USD |
| Non Operating Income Net Other | -212,000USD | 50,000USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 617,000USD | 109,000USD | 596,000USD | 1,832,000USD | 2,401,000USD | 2,683,000USD | 406,000USD | 1,512,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 63,025,000USD | 66,840,000USD | 57,365,000USD | 58,188,000USD | 60,160,000USD | 64,842,000USD | 60,721,000USD | 65,394,000USD |
| Other Current Assets | 1,367,000USD | 1,353,000USD | 1,513,000USD | 1,174,000USD | 1,510,000USD | 1,655,000USD | 2,109,000USD | 1,960,000USD |
| Total Liab | 49,937,000USD | 52,009,000USD | 51,285,000USD | 50,732,000USD | 49,516,000USD | 50,507,000USD | 49,524,000USD | 50,470,000USD |
| Total Stockholder Equity | 12,832,000USD | 14,540,000USD | 5,848,000USD | 7,253,000USD | 10,511,000USD | 14,210,000USD | 11,041,000USD | 14,747,000USD |
| Other Current Liab | 5,663,000USD | 8,214,000USD | 6,171,000USD | 5,794,000USD | 6,401,000USD | 7,058,000USD | 6,792,000USD | 7,180,000USD |
| Common Stock | 42,000USD | 42,000USD | 38,000USD | 38,000USD | 38,000USD | 38,000USD | 35,000USD | 35,000USD |
| Capital Stock | 42,000USD | 42,000USD | 38,000USD | 38,000USD | 38,000USD | 38,000USD | 35,000USD | 35,000USD |
| Retained Earnings | -91,230,000USD | -89,122,000USD | -87,823,000USD | -85,839,000USD | -82,061,000USD | -77,911,000USD | -73,283,000USD | -68,580,000USD |
| Cash | 31,137,000USD | 31,740,000USD | 25,135,000USD | 29,301,000USD | 31,011,000USD | 31,741,000USD | 28,013,000USD | 32,678,000USD |
| Cash And Short Term Investments | 31,137,000USD | 31,740,000USD | 25,135,000USD | 29,301,000USD | 31,011,000USD | 31,741,000USD | 28,013,000USD | 32,678,000USD |
| Total Current Assets | 54,795,000USD | 58,471,000USD | 48,788,000USD | 49,915,000USD | 51,851,000USD | 56,440,000USD | 52,158,000USD | 56,671,000USD |
| Total Current Liabilities | 9,447,000USD | 11,700,000USD | 10,978,000USD | 10,566,000USD | 9,510,000USD | 10,721,000USD | 9,555,000USD | 10,639,000USD |
| Current Deferred Revenue | 714,000USD | — | 1,173,000USD | 1,481,000USD | 430,000USD | 693,000USD | 499,000USD | 778,000USD |
| Net Debt | 8,324,000USD | 7,599,999USD | 14,077,000USD | 9,777,000USD | 7,905,000USD | 7,023,000USD | 10,834,000USD | 6,023,000USD |
| Short Term Debt | 441,000USD | 428,000USD | 414,000USD | 398,000USD | 374,000USD | 355,000USD | 350,000USD | 333,000USD |
| Short Long Term Debt Total | 39,461,000USD | 39,339,999USD | 39,212,000USD | 39,078,000USD | 38,916,000USD | 38,764,000USD | 38,847,000USD | 38,701,000USD |
| Long Term Debt | 35,087,000USD | 34,849,000USD | 34,607,000USD | 34,365,000USD | 34,127,000USD | 33,893,000USD | 33,853,000USD | 33,628,000USD |
| Net Receivables | 12,755,000USD | 16,776,000USD | 12,995,000USD | 11,248,000USD | 11,645,000USD | 15,480,000USD | 13,036,000USD | 12,709,000USD |
| Inventory | 9,536,000USD | 8,602,000USD | 9,145,000USD | 8,192,000USD | 7,685,000USD | 7,564,000USD | 9,000,000USD | 9,324,000USD |
| Accounts Payable | 2,629,000USD | 3,058,000USD | 3,220,000USD | 2,893,000USD | 2,305,000USD | 2,615,000USD | 1,914,000USD | 2,348,000USD |
| Property Plant Equipment Net | 6,327,000USD | 6,617,000USD | 6,765,000USD | 6,550,000USD | 6,537,000USD | 6,738,000USD | 6,778,000USD | 6,912,000USD |
| Property Plant Equipment Gross | 10,693,000USD | 10,910,000USD | 11,035,000USD | 10,670,000USD | 10,590,000USD | 10,727,000USD | 10,667,000USD | 10,695,000USD |
| Common Stock Shares Outstanding | 42,163,000shares | 42,163,000shares | 40,729,000shares | 40,729,000shares | 35,542,000shares | 38,215,000shares | 34,644,000shares | 34,644,000shares |
| Non Current Assets Total | 8,229,999USD | 8,369,000USD | 8,577,000USD | 8,273,000USD | 8,309,000USD | 8,402,000USD | 8,563,000USD | 8,723,000USD |
| Non Current Liabilities Total | 40,489,999USD | 40,309,000USD | 40,306,999USD | 40,166,000USD | 40,006,000USD | 39,786,000USD | 39,969,000USD | 39,831,000USD |
| Non Current Liabilities Other | 339,000USD | 347,000USD | 293,000USD | 292,000USD | 270,000USD | 259,000USD | 201,000USD | 192,000USD |
| Non Currrent Assets Other | 1,902,999USD | 1,752,000USD | 1,812,000USD | 1,723,000USD | 1,772,000USD | 1,664,000USD | 1,785,000USD | 1,811,000USD |
| Net Working Capital | 45,348,000USD | 46,771,000USD | 37,810,000USD | 39,349,000USD | 42,341,000USD | 45,719,000USD | 42,603,000USD | 46,032,000USD |
| Unclassified Non Current Liabilities | 5,063,999USD | 5,113,000USD | 5,406,999USD | 5,509,000USD | 5,609,000USD | 5,634,000USD | 5,915,000USD | 6,011,000USD |
| Unclassified Equity | 103,978,000USD | 103,578,000USD | 93,595,000USD | 93,016,000USD | 92,496,000USD | 92,045,000USD | 84,254,000USD | 83,257,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 66,840,000USD | 64,842,000USD | 79,240,000USD | 51,775,000USD | 68,721,000USD | 74,111,000USD | 84,676,000USD | 95,610,000USD |
| Other Current Assets | 1,353,000USD | 1,655,000USD | 2,764,000USD | 2,737,000USD | 1,926,000USD | 2,795,000USD | 3,582,000USD | 3,465,000USD |
| Total Liab | 52,009,000USD | 50,507,000USD | 52,318,000USD | 13,982,000USD | 14,712,000USD | 10,252,000USD | 13,417,000USD | 7,842,000USD |
| Total Stockholder Equity | 14,540,000USD | 14,210,000USD | 26,701,000USD | 37,582,000USD | 53,704,000USD | 63,721,000USD | 71,259,000USD | 87,768,000USD |
| Other Current Liab | 8,214,000USD | 7,058,000USD | 9,173,000USD | 5,996,000USD | 7,463,000USD | 5,029,000USD | -69,000USD | 6,279,000USD |
| Common Stock | 42,000USD | 38,000USD | 35,000USD | 35,000USD | 34,000USD | 34,000USD | 34,000USD | 34,000USD |
| Capital Stock | 42,000USD | 38,000USD | 35,000USD | 35,000USD | 34,000USD | 34,000USD | 34,000USD | 34,000USD |
| Retained Earnings | -89,122,000USD | -77,911,000USD | -54,448,000USD | -35,735,000USD | -12,551,000USD | 2,621,000USD | 14,517,000USD | 35,512,000USD |
| Cash | 31,740,000USD | 31,741,000USD | 43,652,000USD | 10,192,000USD | 30,870,000USD | 41,915,000USD | 58,812,000USD | 16,466,000USD |
| Cash And Short Term Investments | 31,740,000USD | 31,741,000USD | 43,652,000USD | 10,192,000USD | 30,870,000USD | 41,915,000USD | 58,812,000USD | 78,144,000USD |
| Total Current Assets | 58,471,000USD | 56,440,000USD | 70,362,000USD | 42,972,000USD | 60,737,000USD | 66,089,000USD | 76,664,000USD | 89,517,000USD |
| Total Current Liabilities | 11,700,000USD | 10,721,000USD | 12,740,000USD | 11,850,000USD | 13,205,000USD | 9,153,000USD | 12,242,000USD | 7,702,000USD |
| Net Debt | 7,599,999USD | 7,023,000USD | -5,151,000USD | -9,396,000USD | -30,565,000USD | -41,239,000USD | -57,679,000USD | -16,326,000USD |
| Short Term Debt | 428,000USD | 355,000USD | 367,000USD | 253,000USD | 287,000USD | 364,000USD | 477,000USD | — |
| Short Long Term Debt Total | 39,339,999USD | 38,764,000USD | 38,501,000USD | 796,000USD | 305,000USD | 676,000USD | 1,133,000USD | 140,000USD |
| Long Term Debt | 34,849,000USD | 33,893,000USD | 33,185,000USD | — | — | — | — | 140,000USD |
| Net Receivables | 16,776,000USD | 15,480,000USD | 14,023,000USD | 18,246,000USD | 21,163,000USD | 17,328,000USD | 9,220,000USD | 5,080,000USD |
| Inventory | 8,602,000USD | 7,564,000USD | 9,923,000USD | 11,797,000USD | 6,778,000USD | 4,051,000USD | 5,050,000USD | 5,212,000USD |
| Accounts Payable | 3,058,000USD | 2,615,000USD | 2,712,000USD | 2,669,000USD | 2,631,000USD | 1,511,000USD | 2,438,000USD | 1,423,000USD |
| Property Plant Equipment Net | 6,617,000USD | 6,738,000USD | 7,146,000USD | 7,586,000USD | 6,874,000USD | 7,215,000USD | 7,621,000USD | 5,788,000USD |
| Property Plant Equipment Gross | 10,910,000USD | 10,727,000USD | 10,668,000USD | 7,586,000USD | 6,874,000USD | 7,215,000USD | 7,472,000USD | 5,788,000USD |
| Common Stock Shares Outstanding | 42,163,000shares | 35,542,000shares | 34,622,000shares | 34,516,000shares | 34,332,000shares | 34,212,000shares | 34,069,000shares | 34,366,000shares |
| Non Current Assets Total | 8,369,000USD | 8,402,000USD | 8,878,000USD | 8,803,000USD | 7,984,000USD | 8,022,000USD | 8,012,000USD | 6,093,000USD |
| Non Current Liabilities Total | 40,309,000USD | 39,786,000USD | 39,578,000USD | 2,132,000USD | 1,507,000USD | 1,099,000USD | 1,175,000USD | 140,000USD |
| Non Current Liabilities Other | 347,000USD | 259,000USD | 198,000USD | 724,000USD | 184,000USD | 166,000USD | 1,175,000USD | — |
| Non Currrent Assets Other | 1,752,000USD | 1,664,000USD | 1,732,000USD | 1,217,000USD | 1,110,000USD | 807,000USD | 391,000USD | 114,000USD |
| Net Working Capital | 46,771,000USD | 45,719,000USD | 57,622,000USD | 31,122,000USD | 47,532,000USD | 56,936,000USD | 64,422,000USD | 81,815,000USD |
| Unclassified Non Current Liabilities | 5,113,000USD | 5,634,000USD | 6,195,000USD | — | — | — | — | — |
| Unclassified Equity | 103,578,000USD | 92,045,000USD | 81,079,000USD | 73,247,000USD | 66,187,000USD | 61,032,000USD | 56,674,000USD | 58,546,000USD |
| Current Deferred Revenue | — | 693,000USD | 488,000USD | 853,000USD | 533,000USD | 5,620,000USD | 7,905,000USD | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | -6,358,000USD |
| Other Liab | — | — | — | 1,589,000USD | 1,489,000USD | 787,000USD | 519,000USD | — |
| Other Assets | — | — | — | 1,217,000USD | 1,110,000USD | 1,481,000USD | 191,000USD | 305,000USD |
| Net Tangible Assets | — | — | — | 37,582,000USD | 53,704,000USD | 63,721,000USD | 71,259,000USD | 87,577,000USD |
| Unclassified Non Current Assets | — | — | — | -1,217,000USD | -1,110,000USD | -1,481,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | 2,079,000USD | 2,291,000USD | -3,371,000USD | 1,282,000USD | — |
| Short Long Term Debt | — | — | — | — | — | — | 140,000USD | — |
| Short Term Investments | — | — | — | — | — | — | 0USD | 61,678,000USD |
| Intangible Assets | — | — | — | — | — | — | — | 6,000USD |
| Good Will | — | — | — | — | — | — | — | 185,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -2,384,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -2,108,000USD | -1,218,000USD | -1,984,000USD | -3,738,000USD | -4,150,000USD | -4,659,000USD | -4,768,000USD | -6,556,000USD |
| Depreciation | 202,000USD | 221,000USD | 164,000USD | 132,000USD | 138,000USD | 142,000USD | 144,000USD | 156,000USD |
| Stock Based Compensation | 312,000USD | 500,000USD | 530,000USD | 520,000USD | 451,000USD | 838,000USD | 997,000USD | 1,050,000USD |
| Other Non Cash Items | 545,000USD | 725,000USD | 1,003,000USD | 560,000USD | 266,000USD | 1,136,000USD | -428,000USD | 321,000USD |
| Change To Account Receivables | 3,952,000USD | -3,895,000USD | -1,836,000USD | 471,000USD | 3,942,000USD | -2,914,000USD | -308,000USD | -291,000USD |
| Change To Inventory | -845,000USD | 511,000USD | -865,000USD | -521,000USD | -199,000USD | 1,361,000USD | 355,000USD | 409,000USD |
| Change In Working Capital | 789,000USD | -2,758,000USD | -2,719,000USD | 1,293,000USD | 2,593,000USD | -394,000USD | -385,000USD | 700,000USD |
| Total Cash From Operating Activities | -572,000USD | -2,530,000USD | -3,536,000USD | -1,233,000USD | -702,000USD | -2,937,000USD | -4,440,000USD | -4,329,000USD |
| Capital Expenditures | -60,000USD | -275,000USD | -518,999USD | -265,000USD | -55,000USD | -245,000USD | -153,000USD | -289,000USD |
| Free Cash Flow | -632,000USD | -2,805,000USD | -4,054,999USD | -1,498,000USD | -757,000USD | -3,182,000USD | -4,593,000USD | -4,618,000USD |
| Total Cashflows From Investing Activities | -60,000USD | -275,000USD | -519,000USD | -265,000USD | -55,000USD | -245,000USD | -153,000USD | -289,000USD |
| Net Borrowings | -5,000USD | -6,000USD | -4,000USD | -5,000USD | -5,000USD | -5,000USD | -5,000USD | — |
| Total Cash From Financing Activities | 83,000USD | 9,485,000USD | 45,000USD | 25,000USD | 25,000USD | 6,760,000USD | -5,000USD | -5,000USD |
| Change In Cash | -603,000USD | 6,605,000USD | -4,166,000USD | -1,710,000USD | -730,000USD | 3,728,000USD | -4,665,000USD | -4,604,000USD |
| Begin Period Cash Flow | 31,740,000USD | 25,135,000USD | 29,301,000USD | 31,011,000USD | 31,741,000USD | 28,013,000USD | 32,678,000USD | 37,282,000USD |
| End Period Cash Flow | 31,137,000USD | 31,740,000USD | 25,135,000USD | 29,301,000USD | 31,011,000USD | 31,741,000USD | 28,013,000USD | 32,678,000USD |
| Other Cashflows From Financing Activities | 83,000USD | — | 45,000USD | 30,000USD | 30,000USD | -11,000USD | -153,000USD | -289,000USD |
| Unclassified Financing Cash Flow | — | 9,491,000USD | — | — | — | 6,776,000USD | — | — |
| Investments | — | — | -519,000USD | -265,000USD | -55,000USD | -245,000USD | -153,000USD | -289,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11,105,000USD | -23,559,000USD | -18,850,000USD | -23,278,000USD | -15,200,000USD | -11,906,000USD | -19,706,000USD | 64,009,000USD |
| Depreciation | 655,000USD | 599,000USD | 692,000USD | 890,000USD | 903,000USD | 887,000USD | 754,000USD | 669,000USD |
| Stock Based Compensation | 2,001,000USD | 4,013,000USD | 5,114,000USD | 6,697,000USD | 5,088,000USD | 4,210,000USD | 3,581,000USD | 1,525,000USD |
| Other Non Cash Items | 2,039,000USD | 2,145,000USD | 2,252,000USD | 628,000USD | 603,000USD | 996,000USD | 215,000USD | -68,447,000USD |
| Change To Account Receivables | -1,318,000USD | -2,035,000USD | 3,971,000USD | 1,918,000USD | -4,901,000USD | -558,000USD | -3,790,000USD | -382,000USD |
| Change To Inventory | -1,074,000USD | 2,263,000USD | 1,459,000USD | -5,568,000USD | -2,859,000USD | 615,000USD | -2,367,000USD | -881,000USD |
| Change In Working Capital | -1,591,000USD | -1,245,000USD | 5,543,000USD | -5,217,000USD | -1,843,000USD | -10,253,000USD | -3,319,000USD | -18,399,000USD |
| Total Cash From Operating Activities | -8,001,000USD | -18,047,000USD | -5,249,000USD | -20,280,000USD | -10,449,000USD | -16,066,000USD | -18,475,000USD | -21,011,000USD |
| Capital Expenditures | -1,114,000USD | -722,000USD | -533,000USD | -1,010,000USD | -723,000USD | -581,000USD | -1,301,000USD | -363,000USD |
| Free Cash Flow | -9,115,000USD | -18,769,000USD | -5,782,000USD | -21,290,000USD | -11,172,000USD | -16,647,000USD | -19,776,000USD | -21,374,000USD |
| Total Cashflows From Investing Activities | -1,114,000USD | -722,000USD | 6,734,000USD | -1,010,000USD | -723,000USD | -581,000USD | 60,541,000USD | 29,301,000USD |
| Net Borrowings | -20,000USD | -20,000USD | 35,039,000USD | -148,000USD | -238,000USD | -369,000USD | -60,000USD | -2,694,000USD |
| Total Cash From Financing Activities | 9,580,000USD | 6,745,000USD | 32,166,000USD | 217,000USD | 24,000USD | -73,000USD | 147,000USD | -2,492,000USD |
| Issuance Of Capital Stock | 9,300,000USD | 7,000,000USD | 0USD | — | — | — | — | 0USD |
| Change In Cash | -1,000USD | -11,911,000USD | 33,460,000USD | -20,678,000USD | -11,045,000USD | -16,897,000USD | 42,216,000USD | 5,798,000USD |
| Begin Period Cash Flow | 31,741,000USD | 43,652,000USD | 10,192,000USD | 30,870,000USD | 41,915,000USD | 58,812,000USD | 16,596,000USD | 10,668,000USD |
| End Period Cash Flow | 31,740,000USD | 31,741,000USD | 43,652,000USD | 10,192,000USD | 30,870,000USD | 41,915,000USD | 58,812,000USD | 16,466,000USD |
| Other Cashflows From Financing Activities | 60,000USD | -235,000USD | -5,591,000USD | 365,000USD | 195,000USD | 148,000USD | 207,000USD | 202,000USD |
| Investments | — | -722,000USD | 6,685,000USD | -1,010,000USD | -723,000USD | -581,000USD | 61,842,000USD | -61,431,000USD |
| Other Cashflows From Investing Activities | — | — | -147,000USD | — | -195,000USD | — | 80,726,000USD | 29,664,000USD |
| Unclassified Financing Cash Flow | — | — | 2,718,000USD | — | — | — | — | — |
| Change To Liabilities | — | — | — | -1,141,000USD | 4,550,000USD | -965,000USD | 3,424,000USD | -16,167,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -21,073,000USD | -11,148,000USD | -16,720,000USD | 42,213,000USD | 5,798,000USD |
| Unclassified Investing Cash Flow | — | — | — | 1,010,000USD | — | — | -80,726,000USD | 61,431,000USD |
| Sale Purchase Of Stock | — | — | — | — | 195,000USD | 148,000USD | 207,000USD | 202,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 4,378,000 | USD | 0001437749-26-015652 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 8,112,000 | USD | 0001437749-26-015652 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Oem | 1,756,000 | USD | 0001437749-26-015652 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Surgical Aesthetics | 10,734,000 | USD | 0001437749-26-015652 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 4,214,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 14,950,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 14,043,000 | USD | 0001437749-26-007471 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 38,801,000 | USD | 0001437749-26-007471 |
| FY 2025Yearly · 2025-12-31 | Segment | Oem | 7,512,000 | USD | 0001437749-26-007471 |
| FY 2025Yearly · 2025-12-31 | Segment | Surgical Aesthetics | 45,332,000 | USD | 0001437749-26-007471 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 3,545,000 | USD | 0001437749-25-033499 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 9,332,000 | USD | 0001437749-25-033499 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Oem | 1,812,000 | USD | 0001437749-25-033499 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Surgical Aesthetics | 11,065,000 | USD | 0001437749-25-033499 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 3,597,000 | USD | 0001437749-25-025422 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 7,776,000 | USD | 0001437749-25-025422 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Advanced Energy | 9,670,000 | USD | 0001437749-25-025422 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Oem | 1,703,000 | USD | 0001437749-25-025422 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 2,687,000 | USD | 0001437749-26-015652 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 6,743,000 | USD | 0001437749-26-015652 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Oem | 1,543,000 | USD | 0001437749-26-015652 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Surgical Aesthetics | 7,887,000 | USD | 0001437749-26-015652 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 3,659,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 10,563,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Advanced Energy | 12,099,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Oem | 2,123,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 14,080,000 | USD | 0001437749-26-007471 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 34,022,000 | USD | 0001437749-26-007471 |
| FY 2024Yearly · 2024-12-31 | Segment | Oem | 9,496,000 | USD | 0001437749-26-007471 |
| FY 2024Yearly · 2024-12-31 | Segment | Surgical Aesthetics | 38,606,000 | USD | 0001437749-26-007471 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 3,694,000 | USD | 0001437749-25-033499 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 7,793,000 | USD | 0001437749-25-033499 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Oem | 2,199,000 | USD | 0001437749-25-033499 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Surgical Aesthetics | 9,288,000 | USD | 0001437749-25-033499 |
| Q2 2024Quarterly · 2024-06-30 | Geography | International | 3,462,000 | USD | 0001437749-25-025422 |
| Q2 2024Quarterly · 2024-06-30 | Geography | United States | 8,687,000 | USD | 0001437749-25-025422 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Advanced Energy | 9,766,000 | USD | 0001437749-25-025422 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Oem | 2,383,000 | USD | 0001437749-25-025422 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Advanced Energy | 7,453,000 | USD | 0001437749-25-015356 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Oem | 2,791,000 | USD | 0001437749-25-015356 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 14,004,000 | USD | 0001437749-25-007521 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 38,345,000 | USD | 0001437749-25-007521 |
| FY 2023Yearly · 2023-12-31 | Segment | Advanced Energy | 43,382,000 | USD | 0001437749-25-007521 |
| FY 2023Yearly · 2023-12-31 | Segment | Oem | 8,967,000 | USD | 0001437749-25-007521 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 13,302,000 | USD | 0000719135-24-000016 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 31,208,000 | USD | 0000719135-24-000016 |
| FY 2022Yearly · 2022-12-31 | Segment | Advanced Energy | 36,803,000 | USD | 0000719135-24-000016 |
| FY 2022Yearly · 2022-12-31 | Segment | OEM | 7,707,000 | USD | 0000719135-24-000016 |
| FY 2021Yearly · 2021-12-31 | Geography | International | 15,537,000 | USD | 0000719135-23-000018 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 32,980,000 | USD | 0000719135-23-000018 |
| FY 2021Yearly · 2021-12-31 | Segment | Advanced Energy | 42,985,000 | USD | 0000719135-23-000018 |
| FY 2021Yearly · 2021-12-31 | Segment | OEM | 5,532,000 | USD | 0000719135-23-000018 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 8,899,000 | USD | 0000719135-22-000020 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 18,812,000 | USD | 0000719135-22-000020 |
| FY 2020Yearly · 2020-12-31 | Segment | Advanced Energy | 22,214,000 | USD | 0000719135-22-000020 |
| FY 2020Yearly · 2020-12-31 | Segment | OEM | 5,497,000 | USD | 0000719135-22-000020 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 8,651,000 | USD | 0000719135-21-000029 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 19,584,000 | USD | 0000719135-21-000029 |
| FY 2019Yearly · 2019-12-31 | Segment | Advanced Energy | 22,676,000 | USD | 0000719135-21-000029 |
| FY 2019Yearly · 2019-12-31 | Segment | OEM | 5,559,000 | USD | 0000719135-21-000029 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 3,828 | USD | 0001628280-19-002892 |
| FY 2018Yearly · 2018-12-31 | Geography | Other | 3,824,172 | USD | 0001628280-19-002892 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 12,858,000 | USD | 0001628280-19-002892 |
| FY 2018Yearly · 2018-12-31 | Segment | Advanced Energy | 12,987,000 | USD | 0000719135-20-000029 |
| FY 2018Yearly · 2018-12-31 | Segment | OEM | 3,618,000 | USD | 0000719135-20-000029 |
| FY 2017Yearly · 2017-12-31 | Product | Cauteries | 7,141,000 | USD | 0000719135-18-000015 |
| FY 2017Yearly · 2017-12-31 | Product | Electrosurgical | 25,727,000 | USD | 0000719135-18-000015 |
| FY 2017Yearly · 2017-12-31 | Product | Lighting | 2,435,000 | USD | 0000719135-18-000015 |
| FY 2017Yearly · 2017-12-31 | Product | Other | 3,580,000 | USD | 0000719135-18-000015 |
| Q4 2017Quarterly · 2017-12-31 | Product | Cauteries | 1,917,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Electrosurgical | 7,986,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Lighting | 469,000 | USD | Legacy provider |
| Q4 2017Quarterly · 2017-12-31 | Product | Other | 976,000 | USD | Legacy provider |
| Q3 2017Quarterly · 2017-09-30 | Product | Cauteries | 1,696,000 | USD | 0000719135-17-000064 |
| Q3 2017Quarterly · 2017-09-30 | Product | Electrosurgical | 6,205,000 | USD | 0000719135-17-000064 |
| Q3 2017Quarterly · 2017-09-30 | Product | Lighting | 573,000 | USD | 0000719135-17-000064 |
| Q3 2017Quarterly · 2017-09-30 | Product | Other | 873,000 | USD | 0000719135-17-000064 |
| Q2 2017Quarterly · 2017-06-30 | Product | Cauteries | 1,873,000 | USD | 0000719135-17-000029 |
| Q2 2017Quarterly · 2017-06-30 | Product | Electrosurgical | 6,206,000 | USD | 0000719135-17-000029 |
| Q2 2017Quarterly · 2017-06-30 | Product | Lighting | 948,000 | USD | 0000719135-17-000029 |
| Q2 2017Quarterly · 2017-06-30 | Product | Other | 772,000 | USD | 0000719135-17-000029 |
| Q1 2017Quarterly · 2017-03-31 | Product | Cauteries | 1,655,000 | USD | 0000719135-17-000016 |
| Q1 2017Quarterly · 2017-03-31 | Product | Electrosurgical | 5,330,000 | USD | 0000719135-17-000016 |
| Q1 2017Quarterly · 2017-03-31 | Product | Lighting | 445,000 | USD | 0000719135-17-000016 |
| Q1 2017Quarterly · 2017-03-31 | Product | Other | 959,000 | USD | 0000719135-17-000016 |
| FY 2016Yearly · 2016-12-31 | Product | Cauteries | 7,101,000 | USD | 0000719135-18-000015 |
| FY 2016Yearly · 2016-12-31 | Product | Electrosurgical | 20,901,000 | USD | 0000719135-18-000015 |
| FY 2016Yearly · 2016-12-31 | Product | Lighting | 2,710,000 | USD | 0000719135-18-000015 |
| FY 2016Yearly · 2016-12-31 | Product | Other | 5,915,000 | USD | 0000719135-18-000015 |
| Q4 2016Quarterly · 2016-12-31 | Product | Cauteries | 1,684,000 | USD | Legacy provider |
| Q4 2016Quarterly · 2016-12-31 | Product | Electrosurgical | 5,881,000 | USD | Legacy provider |
| Q4 2016Quarterly · 2016-12-31 | Product | Lighting | 664,000 | USD | Legacy provider |
| Q4 2016Quarterly · 2016-12-31 | Product | Other | 1,265,000 | USD | Legacy provider |
| Q3 2016Quarterly · 2016-09-30 | Product | Cauteries | 1,863,000 | USD | 0000719135-17-000064 |
| Q3 2016Quarterly · 2016-09-30 | Product | Electrosurgical | 5,690,000 | USD | 0000719135-17-000064 |
| Q3 2016Quarterly · 2016-09-30 | Product | Lighting | 740,000 | USD | 0000719135-17-000064 |
| Q3 2016Quarterly · 2016-09-30 | Product | Other | 1,770,000 | USD | 0000719135-17-000064 |
| Q2 2016Quarterly · 2016-06-30 | Product | Cauteries | 1,720,000 | USD | 0000719135-17-000029 |
| Q2 2016Quarterly · 2016-06-30 | Product | Electrosurgical | 5,078,000 | USD | 0000719135-17-000029 |
| Q2 2016Quarterly · 2016-06-30 | Product | Lighting | 800,000 | USD | 0000719135-17-000029 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.